A Simple Method for Quantifying Functional Selectivity and Agonist Bias

被引:368
作者
Kenakin, Terry [1 ]
Watson, Christian [2 ]
Muniz-Medina, Vanessa [3 ]
Christopoulos, Arthur [4 ,5 ]
Novick, Steven [6 ]
机构
[1] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] GlaxoSmithKline Res, Platform Technol Sci, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline Res, Infect Dis Discovery Performance Unit, Res Triangle Pk, NC 27709 USA
[4] Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic 3004, Australia
[5] Monash Univ, Dept Pharmacol, Melbourne, Vic 3004, Australia
[6] GlaxoSmithKline Res, Discovery Analyt, Res Triangle Pk, NC 27709 USA
来源
ACS CHEMICAL NEUROSCIENCE | 2012年 / 3卷 / 03期
关键词
Biased agonism; drug discovery; functional selectivity; receptor theory; receptor methods; stimulus bias; PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; PHARMACOLOGICAL AGONISM; INTERACTING PROTEINS; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; SMOOTH-MUSCLE; ACTIVE STATE; EFFICACY; LIGANDS;
D O I
10.1021/cn200111m
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of seven-transmembrane (7TM) receptors by agonists does not always lead to uniform activation of all signaling pathways mediated by a given receptor. Relative to other ligands, many agonists are "biased" toward producing subsets of receptor behaviors. A hallmark of such "functional selectivity" is cell type dependence; this poses a particular problem for the profiling of agonists in whole cell test systems removed from the therapeutic one(s). Such response-specific cell-based variability makes it difficult to guide medicinal chemistry efforts aimed at identifying and optimizing therapeutically meaningful agonist bias. For this reason, we present a scale, based on the Black and Leff operational model, that contains the key elements required to describe 7TM agonism, namely, affinity (K-A(-1)) for the receptor and efficacy (tau) in activating a particular signaling pathway. Utilizing a "transduction coefficient" term, log(tau/K-A), this scale can statistically evaluate selective agonist effects in a manner that can theoretically inform structure activity studies and/or drug candidate selection matrices. The bias of four chemokines for CCRS-mediated inositol phosphate production versus internalization is quantified to illustrate the practical application of this method. The independence of this method with respect to receptor density and the calculation of statistical estimates of confidence of differences are specifically discussed.
引用
收藏
页码:193 / 203
页数:11
相关论文
共 38 条
[1]   OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM [J].
BLACK, JW ;
LEFF, P .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219) :141-162
[2]   AN OPERATIONAL MODEL OF PHARMACOLOGICAL AGONISM - THE EFFECT OF E/[A] CURVE SHAPE ON AGONIST DISSOCIATION-CONSTANT ESTIMATION [J].
BLACK, JW ;
LEFF, P ;
SHANKLEY, NP ;
WOOD, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 84 (02) :561-571
[3]   G protein-coupled receptor interacting proteins: Emerging roles in localization and signal transduction [J].
Brady, AE ;
Limbird, LE .
CELLULAR SIGNALLING, 2002, 14 (04) :297-309
[4]   IMPRECISION IN PRESENTATION OF BINDING-STUDIES [J].
COLQUHOUN, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1985, 6 (05) :197-197
[5]   Analysis of allosterism in functional assays [J].
Ehlert, FJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (02) :740-754
[6]   Selectivity of Agonists for the Active State of M1 to M4 Muscarinic Receptor Subtypes [J].
Figueroa, Katherine W. ;
Griffin, Michael T. ;
Ehlert, Frederick J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (01) :331-342
[7]  
Furchgott R., 1966, ADV DRUG RES, V3, P21
[8]   Distinct signaling profiles of β1 and β2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy [J].
Galandrin, Segolene ;
Bouvier, Michel .
MOLECULAR PHARMACOLOGY, 2006, 70 (05) :1575-1584
[9]   The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility [J].
Gonzalez, E ;
Kulkarni, H ;
Bolivar, H ;
Mangano, A ;
Sanchez, R ;
Catano, G ;
Nibbs, RJ ;
Freedman, BI ;
Quinones, MP ;
Bamshad, MJ ;
Murthy, KK ;
Rovin, BH ;
Bradley, W ;
Clark, RA ;
Anderson, SA ;
O'Connell, RJ ;
Agan, BK ;
Ahuja, SS ;
Bologna, R ;
Sen, L ;
Dolan, MJ ;
Ahuja, SK .
SCIENCE, 2005, 307 (5714) :1434-1440
[10]   ETHYLENEIMINIUM ION AS THE ACTIVE SPECIES IN 2-HALOALKYLAMINE COMPOUNDS [J].
GRAHAM, JDP .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (04) :489-497